Ariana Resources PLC (AIM:AAU)'s newly upgraded Slivova gold project fits the AIM-quoted gold company’s “sweet-spot” easily, so says WH Ireland analyst Paul Smith.
Ariana, via 75%-owned Western Tethyan Resources Ltd, today revealed a new major increase in gold resources at Slivova, in Kosovo, where total resource ounces now exceed 645,000.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) agreement with Mosaic for Brazil rare earths project “offers significant upside potential for Rainbow” according to Berenberg.
Mosaic is a major producer of phosphoric acid in Brazil and the broker expects the Uberaba project to be larger than the Phalaborwa project in scale, which Berenberg believes to be “one of the best, highest-margin undeveloped rare-earth projects globally.”
Diversified Energy Company PLC (LSE:DEC, OTCQX:DECPF) (DEC) has announced a further divestment of assets, with the sale of a package of 22,000 net acres of undeveloped ground in Oklahoma, in a transaction worth US$16 million.
The deal, with an unnamed counterparty, demonstrates the company’s ability to realise upside from within its portfolio by monetising undeveloped and non-core acreage, and is well-aligned with its strategic focus on its operated and more advanced projects, DEC highlighted.
Liberum has called Haleon PLC (LSE:HLN, NYSE:HLN) an “excellent choice” to take on commercialisation responsibilities in the US Futura Medical PLC (AIM:FUM, OTC:FAMDF)’s MED3000 topical, gel-based erectile dysfunction treatment.
Haleon, the 2022 spin-out from GSK, will now be responsible for all investments and activities related to the launch and marketing of the product in the US, while Futura will provide ongoing technical support for over-the-counter product development and commercialisation opportunities.
To say that Rio Tinto Plc's (LSE:RIO) strategic investment in Sovereign Metals Limited (ASX:SVM, OTC:SVMLF, AIM:SVML) is a ‘positive’ may be something of an understatement, indeed, in London the exploration share shot up nearly 25% following Monday’s news.
Rio is taking a 15% stake in the ASX and AIM-listed mining junior in exchange for a A$40 million investment to help drive forward the Kasiya rutile-graphite project in Malawi.
Ondine Biomedical Inc (AIM:OBI) has received the Tayyaba Hasan Impact Award at the 18th International Photodynamic Association (IPA) World Congress, which took place in Finland.
The award recognised Ondine for “demonstrating exceptional perseverance and clinical acumen".
Sovereign Metals Limited (ASX:SVM, OTC:SVMLF, AIM:SVML) shares shot up 26% in Monday morning’s deals after Rio Tinto was revealed as its new strategic investors, pumping in some A$40.4mln to help fund the Kasiya rutile-graphite project in Malawi.
Rio takes a 15% stake in the AIM and ASX quoted small-cap as a result of the investment, plus options to increase its interest to 19.99% within 12 months.
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) has provided an update on the construction of its second tailings dam in the Gedabek district of Azerbaijan.
The gold, copper and silver producer said the preferred site for the dam, located near its existing dam, has received the necessary land allocation from the government of Azerbaijan.
Futura Medical PLC (AIM:FUM, OTC:FAMDF) surged in Monday’s early trades following a bullish announcement regarding its MED3000 topical, gel-based erectile dysfunction treatment.
The group has entered into a licensing agreement with world-leading consumer health company Haleon PLC (LSE:HLN, NYSE:HLN) for the exclusive US commercialisation rights to MED3000.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) has inked a memorandum of understanding with an industry leader that it said represents a major opportunity to advance a project in Brazil.
The agreement is with Mosaic Company, described by Rainbow as “the world's leading integrated producer of concentrated phosphate and potash”, and it sets out a potential collaboration to jointly develop a process flowsheet to extract the rare earth elements from the Uberaba project, in the Minas Gerais region.
Cordiant Digital Infrastructure Ltd (LSE:CORD), an operationally focused communication and internet infrastructure investor, has announced that its portfolio company Emitel has secured a refinancing agreement.
The deal relates to Polish infrastructure group Emitel’s senior loan facilities with a consortium of leading international and national lenders, under which it has secured 1.57bn zloty (£300mln) of financing, maturing in 2030.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) has restated its full-year guidance for the Blanket Mine in Zimbabwe, estimating gold production to be between 75,000 and 80,000 ounces for 2023.
For the quarter ended 30 June 2023, production at Blanket was 17,436 ounces of gold, representing an 8.7% increase on the 16,036 ounces produced in the first quarter of 2023. Gold produced at Blanket in the first six months of 2023 was 33,472 ounces, compared to 38,606 ounces produced in the first half of 2022.
Mosman Oil and Gas Ltd (AIM:MSMN) told investors it has inked a non-binding heads of agreement which sets out a potential offtake for helium from its exploration block in the Amadeus Basin in central Australia.
The early-stage agreement is with Beijing Sinoscience Fullcyro Technology and Beltway Group.
Ariana Resources PLC (AIM:AAU) has confirmed a new resource upgrade at the Slivova gold project in Kosovo, held via its 75%-owned Western Tethyan Resources Ltd.
The new view of Slivova sees a 78% increase in gold ounces from the prior estimate, with total resource ounces now exceeding 175,000 ounces of gold.
Cellular Goods PLC (LSE:CBX) has announced that its subsidiary King Tide Carbon will create a new joint venture to develop carbon sequestration and removal services in the kelp farming industry.
King Tide has signed a memorandum of understanding to partner with Springtide Seaweed - one of America’s largest organic kelp farms - for two years, Cellular announced on Monday.
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has entered into a licensing agreement with world-leading consumer health company Haleon PLC (LSE:HLN, NYSE:HLN) for the exclusive US commercialisation rights to Futura’s topical, gel-based erectile dysfunction (ED) treatment MED3000.
AIM-listed Futura, whose sexual health-focused proprietary drug technology DermaSys is in clinical development, said it will receive an upfront payment of US$4mln (£3mln), followed by royalty payments on all MED3000 sales by Haleon.
Sovereign Metals Limited (ASX:SVM, OTC:SVMLF, AIM:SVML) has attracted the attention of global mining giant Rio Tinto PLC (LSE:RIO), with the mega-cap to invest $40.4 million to become a 15% shareholder in the junior miner.
The investment will advance the Kasiya Rutile-Graphite Project in Malawi, unlocking a significant supply of low-carbon-footprint natural rutile and flake graphite.